Shorter Leukocyte Telomere Length May Help Identify Patients With COPD At Increased Risk For Accelerated Disease Progression, Poor Outcomes, Research Suggests.

MedPage Today (7/19, Boyles) reports that an analysis suggests “shorter leukocyte telomere length may represent a clinically translatable biomarker for identifying COPD patients at increased risk for accelerated disease progression and poor outcomes.” Ad...